ARTICLE SUMMARY:
Welcome to the September 18 edition of Pathways’ Picks, MTS Market Pathways’ weekly roundup of the most important global medtech regulatory, reimbursement, and policy news. This week: FDA plays it safe, Medicare debates, news from Europe, dates to remember, and more.
FDA rolled out its promised proposal for a Breakthrough-like program focused on innovations that are expressly designed to improve device safety in a September 18-posted draft guidance. That news leads our Pathways’ Picks—a rundown of medtech policy happenings and key dates that should be on your radar this week.
